Status:
NOT_YET_RECRUITING
Establishment of Cohort Under the Guidance of the Pathogenesis of Cancer Toxin in Traditional Chinese Medicine
Lead Sponsor:
Ying Zhang
Collaborating Sponsors:
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dongzhimen Hospital, Beijing
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The study aims to investigate the potential mechanisms by which the interaction between the microbiota and tumors leads to the occurrence and development of cancer by collecting clinical information a...
Detailed Description
Study Design Types: A prospective, multicenter, observational study. Observation Content:1.Healthy Individuals:General Information (Demographic Data), Traditional Chinese Medicine Physical Quality Sc...
Eligibility Criteria
Inclusion
- Inclusion criteria for healthy individuals:
- Age ≥ 18 years old;
- Informed consent and signed informed consent form.
- Inclusion criteria for patients with malignant tumors:
- Patients with malignant tumors diagnosed by pathology or cytology;
- Advanced stage patients who have not received modern medical treatment in the past, or early to mid-stage patients who have completed postoperative radiochemotherapy for ≥ 1 month;
- Age ≥ 18 years old;
- Informed consent and signed informed consent form.
Exclusion
- Exclusion criteria for healthy individuals:
- Patients with malignant tumors diagnosed by pathology or cytology;
- Those who have taken any antibiotics/probiotics within 1 month before biological sample collection;
- Those with other immune or infectious diseases;
- Those with severe damage to the heart, liver, lungs, or kidney functions;
- Pregnant women, or those with mental illnesses such as depression or schizophrenia;
- Those deemed ineligible for the study by the researcher.
- Exclusion criteria for patients with malignant tumors:
- Patients with multiple primary cancers;
- Those who have taken any antibiotics/probiotics within 1 month before biological sample collection;
- Those with other immune or infectious diseases;
- Those with severe damage to the heart, liver, lungs, or kidney functions;
- Pregnant women, or those with mental illnesses such as depression or schizophrenia;
- Those deemed ineligible for the study by the researcher.
Key Trial Info
Start Date :
September 22 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06612216
Start Date
September 22 2024
End Date
February 28 2027
Last Update
September 25 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.